Thomas Geer

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Christoph Röllig, Hubert Serve, Andreas Hüttmann et al. · The Lancet Oncology · 2015 · 395 citations · Full text

Sorafenib Versus Placebo, Hematological Malignancy, Oncology +9

Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

Hannes Wandt, Markus H. Frank, Gerhard Ehninger et al. · Blood · 1998 · 298 citations · Full text

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

Volker Kunzmann, Jens T. Siveke, Hana Algül et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 184 citations

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +9

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer

Markus Moehler, Antje Eimermacher, Juergen Siebler et al. · British Journal of Cancer · 2005 · 97 citations · Full text

SUBCLAVIAN ARTERY TRAUMA

Norman M. Rich, Robert W. Hobson, Bruce S. Jarstfer et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 1973 · 91 citations

Trauma Resuscitation, Usa Author Information, Humanities +14